These outcomes, together with a former report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 assist the notion of focusing on ACKR3 as a unique strategy to modulate the opioid method, which could open new therapeutic avenues for opioid-connected